Baker Brothers Advisors - NEOLEUKIN THERAPEUTICS INC ownership

NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104. A total of 41 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of NEOLEUKIN THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$3,172,044
+18.6%
3,821,7400.0%0.02%
+20.0%
Q1 2023$2,675,218
+37.5%
3,821,7400.0%0.02%
+25.0%
Q4 2022$1,945,266
-20.5%
3,821,7400.0%0.01%
-25.0%
Q3 2022$2,446,000
-37.9%
3,821,7400.0%0.02%
-27.3%
Q2 2022$3,936,000
-45.2%
3,821,7400.0%0.02%
-46.3%
Q1 2022$7,185,000
-61.0%
3,821,7400.0%0.04%
-54.4%
Q4 2021$18,421,000
-33.3%
3,821,7400.0%0.09%
-25.6%
Q3 2021$27,631,000
-21.7%
3,821,7400.0%0.12%
-21.9%
Q2 2021$35,275,000
-25.0%
3,821,7400.0%0.16%
-24.0%
Q1 2021$47,046,000
-12.7%
3,821,7400.0%0.20%
+0.5%
Q4 2020$53,887,000
+17.5%
3,821,7400.0%0.20%
+10.9%
Q3 2020$45,861,000
-18.7%
3,821,740
+12.5%
0.18%
-26.5%
Q2 2020$56,402,000
+45.9%
3,397,7400.0%0.25%
+4.6%
Q1 2020$38,666,000
-7.6%
3,397,7400.0%0.24%
+6.7%
Q4 2019$41,860,000
+29.9%
3,397,740
-69.9%
0.22%
+1.8%
Q3 2019$32,221,00011,305,6790.22%
Other shareholders
NEOLEUKIN THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Opaleye Management Inc. 1,047,300$5,048,0001.07%
ACT CAPITAL MANAGEMENT, LLC 212,500$1,024,0000.74%
Redmile Group, LLC 3,490,835$16,826,0000.38%
Kynam Capital Management, LP 147,000$709,0000.38%
EcoR1 Capital, LLC 860,619$4,148,0000.13%
Baker Brothers Advisors 3,821,740$18,421,0000.09%
GSA CAPITAL PARTNERS LLP 130,899$631,0000.08%
Sio Capital Management, LLC 38,312$185,0000.06%
Highland Private Wealth Management 46,999$227,0000.03%
XTX Topco Ltd 10,018$48,0000.03%
View complete list of NEOLEUKIN THERAPEUTICS INC shareholders